Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: nowandthen who wrote (17111)	12/10/2004 12:13:52 PM
From: zax	Read Replies (1) \| Respond to of 17367

>> You're full of crap.Enbrel, Humira and Remicade have FATAL side effects,RAPTIVA much better drug. First of all, Raptiva is not approved for psoriatic arthritis, only for psoriasis. XOMA withrew it from trials, after a collosal failure in trials. Enbrel, Humira and Remicade all treat both conditions, as well as Rheumatoid arthritis, Crohn's disease, and more. Since many people with psoriasis develop psoriatic arthritis, this immediately limits the use of the drug. All of these drugs are immunosuppressants, so there are none that are perfectly safe. I don't believe that the (quite low) mortality rates are any higher or lower for Raptiva than any of these others. But the horrible side effects from Raptiva reported by many while on Raptiva (i.e., guttate and pa onset), and the universal, disfiguring outbreaks people experience when going off of this drug, lasting many weeks, is causing many derms to cease prescribing it. And it is accepted that the absolute best treatment available right now is Remicade, althrough its quite difficult to get insurance to cover this drug due to its expense. I'm a little confused - What was your point in posting a link to the "Raptiva Sucks" thread where people on NPF are all talking about their nightmares with Raptiva?